 INDIANAPOLIS, and DURHAM, N.C., Nov. 20, 2020 PRNewswire -- Eli Lilly and Company NYSE: LLY and Precision BioSciences, Inc. Nasdaq: DTIL today announced a research collaboration and exclusive license agreement to utilize Precisions proprietary ARCUS genome editing platform for the... 